Thomas J. Tisch, Director at SYNAGEVA BIOPHARMA CORP (GEVA), bought 21,039 shares at $47.53 ($1000K) on 2013-01-09, disclosed to the SEC on 2013-01-15.
Open-market purchase of $1000k GEVA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| GEVA | BUY | 2012-01-17 | $3.0M | — | Filing → |
| GEVA | BUY | 2012-01-11 | $30.2M | — | Filing → |